|
ZNF347 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63247193540883E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.5743964172118E-11 |
| Normal-vs-Stage2 |
4.84960000046719E-07 |
| Normal-vs-Stage3 |
4.49107417921368E-12 |
| Normal-vs-Stage4 |
3.27780025344282E-11 |
| Stage1-vs-Stage2 |
8.671400E-01 |
| Stage1-vs-Stage3 |
1.353170E-01 |
| Stage1-vs-Stage4 |
1.593790E-02 |
| Stage2-vs-Stage3 |
3.650000E-01 |
| Stage2-vs-Stage4 |
1.266560E-01 |
| Stage3-vs-Stage4 |
4.010000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.70006239588838E-13 |
| Normal-vs-AfricanAmerican |
7.54849999999863E-05 |
| Normal-vs-Asian |
2.98340000037811E-07 |
| Caucasian-vs-AfricanAmerican |
7.306800E-01 |
| Caucasian-vs-Asian |
7.728400E-01 |
| AfricanAmerican-vs-Asian |
9.020400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.68190025742854E-10 |
| Normal-vs-Female |
2.25652829755063E-12 |
| Male-vs-Female |
2.625000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.21699983424151E-10 |
| Normal-vs-Age(41-60Yrs) |
1.38260514148669E-11 |
| Normal-vs-Age(61-80Yrs) |
2.63360000474222E-10 |
| Normal-vs-Age(81-100Yrs) |
2.976900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.424800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.108760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.436600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.750600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.858600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.834000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.007520E-02 |
| Classical-VS-Follicular |
3.733400E-01 |
| Classical-VS-Other |
1.213780E-01 |
| Classical-VS-Normal |
2.57259999969506E-08 |
| Tall-VS-Follicular |
8.304400E-02 |
| Tall-VS-Other |
7.927200E-01 |
| Tall-VS-Normal |
9.51450029873513E-11 |
| Follicular-VS-Other |
3.714600E-01 |
| Follicular-VS-Normal |
4.25210000543075E-08 |
| Other-VS-Normal |
6.370400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.15587572635923E-13 |
| Normal-vs-N1 |
6.78419986854806E-10 |
| N0-vs-N1 |
3.494800E-01 |
|
|
